Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag The Supreme Court will decide if federal approval of Roundup blocks state cancer lawsuits against Bayer.

flag The U.S. Supreme Court will hear Bayer’s appeal in a major case over Roundup weedkiller, challenging whether the Environmental Protection Agency’s approval of glyphosate—without a cancer warning—preempts state lawsuits claiming the product causes cancer. flag The case centers on a Missouri man who won a $1.25 million verdict after developing non-Hodgkin’s lymphoma from long-term Roundup use. flag While the EPA maintains glyphosate is not likely carcinogenic when used as directed, some studies suggest a link, and the International Agency for Research on Cancer classifies it as “probably carcinogenic.” Bayer, which acquired Monsanto in 2018, argues federal preemption should block state claims, citing conflicting lower court rulings and seeking to limit liability. flag The company has set aside $16 billion to settle claims, stopped selling glyphosate-based Roundup for residential use, and pushed for state laws banning lawsuits, with Georgia and North Dakota complying. flag The Trump administration supports Bayer, reversing the Biden administration’s position. flag The Court’s decision could affect about 181,000 claims and determine whether Bayer continues selling glyphosate in U.S. agriculture. flag The argument date is pending.

101 Articles